SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon
Many African countries have reported relatively low numbers of COVID-19 cases but the true scale of the epidemic is unclear. Here, the authors conduct a population-based survey in a province of Cameroon and estimate 29% seroprevlance, >300 fold higher than the nationwide attack rate implied by ca...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2021-10-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-021-25946-0 |
| id |
doaj-c0db4eec44b5484f96f1e8b55f5e0a91 |
|---|---|
| record_format |
Article |
| spelling |
doaj-c0db4eec44b5484f96f1e8b55f5e0a912021-10-10T11:45:55ZengNature Publishing GroupNature Communications2041-17232021-10-011211910.1038/s41467-021-25946-0SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in CameroonKene Nwosu0Joseph Fokam1Franck Wanda2Lucien Mama3Erol Orel4Nicolas Ray5Jeanine Meke6Armel Tassegning7Desire Takou8Eric Mimbe9Beat Stoll10Josselin Guillebert11Eric Comte12Olivia Keiser13Laura Ciaffi14Institute of Global Health, University of GenevaChantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and ManagementCentre International de Recherches, d’Enseignements, et de Soins (CIRES)Health District of Cite Verte, Regional Delegation of Public HealthInstitute of Global Health, University of GenevaInstitute of Global Health, University of GenevaCentre International de Recherches, d’Enseignements, et de Soins (CIRES)Centre International de Recherches, d’Enseignements, et de Soins (CIRES)Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and ManagementSite de Coordination ANRS Cameroun, Hopital Central de YaoundeInstitute of Global Health, University of GenevaDeutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbHInstitute of Global Health, University of GenevaInstitute of Global Health, University of GenevaSite de Coordination ANRS Cameroun, Hopital Central de YaoundeMany African countries have reported relatively low numbers of COVID-19 cases but the true scale of the epidemic is unclear. Here, the authors conduct a population-based survey in a province of Cameroon and estimate 29% seroprevlance, >300 fold higher than the nationwide attack rate implied by case counts.https://doi.org/10.1038/s41467-021-25946-0 |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Kene Nwosu Joseph Fokam Franck Wanda Lucien Mama Erol Orel Nicolas Ray Jeanine Meke Armel Tassegning Desire Takou Eric Mimbe Beat Stoll Josselin Guillebert Eric Comte Olivia Keiser Laura Ciaffi |
| spellingShingle |
Kene Nwosu Joseph Fokam Franck Wanda Lucien Mama Erol Orel Nicolas Ray Jeanine Meke Armel Tassegning Desire Takou Eric Mimbe Beat Stoll Josselin Guillebert Eric Comte Olivia Keiser Laura Ciaffi SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon Nature Communications |
| author_facet |
Kene Nwosu Joseph Fokam Franck Wanda Lucien Mama Erol Orel Nicolas Ray Jeanine Meke Armel Tassegning Desire Takou Eric Mimbe Beat Stoll Josselin Guillebert Eric Comte Olivia Keiser Laura Ciaffi |
| author_sort |
Kene Nwosu |
| title |
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon |
| title_short |
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon |
| title_full |
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon |
| title_fullStr |
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon |
| title_full_unstemmed |
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon |
| title_sort |
sars-cov-2 antibody seroprevalence and associated risk factors in an urban district in cameroon |
| publisher |
Nature Publishing Group |
| series |
Nature Communications |
| issn |
2041-1723 |
| publishDate |
2021-10-01 |
| description |
Many African countries have reported relatively low numbers of COVID-19 cases but the true scale of the epidemic is unclear. Here, the authors conduct a population-based survey in a province of Cameroon and estimate 29% seroprevlance, >300 fold higher than the nationwide attack rate implied by case counts. |
| url |
https://doi.org/10.1038/s41467-021-25946-0 |
| work_keys_str_mv |
AT kenenwosu sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT josephfokam sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT franckwanda sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT lucienmama sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT erolorel sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT nicolasray sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT jeaninemeke sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT armeltassegning sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT desiretakou sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT ericmimbe sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT beatstoll sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT josselinguillebert sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT ericcomte sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT oliviakeiser sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT lauraciaffi sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon |
| _version_ |
1716829622144860160 |